Expression of TBX3 in Hepatocellular Carcinoma and Its Clinical Implication (Q61455365)

2

0 references

Shasha Duan

3

0 references

Yilu Shi

4

0 references

Shuling Li

5

0 references

Xiaoshan Zhang

6

0 references

Jianjun Ren

7

0 references

language of work or name

English

0 references

publication date

22 December 2018

0 references

number of pages

10

1 reference

p19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes

inferred from page(s)

published in

Medical Science Monitor

0 references

volume

24

0 references

page(s)

9324-9333

0 references

cites work

1 reference

12 December 2020

Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis

1 reference

12 December 2020

Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.

1 reference

12 December 2020

TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases

1 reference

12 December 2020

Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression

1 reference

12 December 2020

Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.

1 reference

12 December 2020

Tbx3 improves the germ-line competency of induced pluripotent stem cells

1 reference

12 December 2020

SMAD3 and EGR1 physically and functionally interact in promoter-specific fashion

1 reference

12 December 2020

TBX2 and TBX3: the special value for anticancer drug targets.

1 reference

12 December 2020

Liver cancer epidemic in China: past, present and future

1 reference

12 December 2020

Basal transcription of the human TBX3 gene, a key developmental regulator which is overexpressed in several cancers, requires functional NF-Y and Sp1 sites

1 reference

12 December 2020

Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers

1 reference

12 December 2020

Diverse functional networks of Tbx3 in development and disease

1 reference

12 December 2020

Effects of low concentrations of regorafenib and sorafenib on human HCC cell AFP, migration, invasion, and growth in vitro.

1 reference

12 December 2020

Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion

1 reference

12 December 2020

Effects of AFP-activated PI3K/Akt signaling pathway on cell proliferation of liver cancer

1 reference

12 December 2020

Phenotype of a patient with contiguous deletion of TBX5 and TBX3: expanding the disease spectrum

1 reference

12 December 2020

The T-box gene family: emerging roles in development, stem cells and cancer

1 reference

12 December 2020

Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma.

1 reference

12 December 2020

Tbx3 Controls Dppa3 Levels and Exit from Pluripotency toward Mesoderm

1 reference

12 December 2020

Cancer statistics in China, 2015.

1 reference

12 December 2020

[Inhibitory effect of Biejiajian pills on HepG2 cell xenograft growth and expression of β-catenin and Tbx3 in nude mice]

1 reference

12 December 2020

Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer

1 reference

12 December 2020

Cancer incidence and mortality in China in 2013: an analysis based on urbanization level.

1 reference

12 December 2020

The tumour suppressor, miR-137, inhibits malignant melanoma migration by targetting the TBX3 transcription factor

1 reference

12 December 2020